Supernus Pharmaceuticals (SUPN) Leases (2019 - 2025)
Historic Leases for Supernus Pharmaceuticals (SUPN) over the last 7 years, with Q3 2025 value amounting to $28.8 million.
- Supernus Pharmaceuticals' Leases changed N/A to $28.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.8 million, marking a year-over-year change of. This contributed to the annual value of $24.5 million for FY2024, which is 1557.91% down from last year.
- Supernus Pharmaceuticals' Leases amounted to $28.8 million in Q3 2025.
- Supernus Pharmaceuticals' 5-year Leases high stood at $35.4 million for Q4 2021, and its period low was $21.9 million during Q2 2025.
- Over the past 5 years, Supernus Pharmaceuticals' median Leases value was $29.3 million (recorded in 2022), while the average stood at $28.6 million.
- In the last 5 years, Supernus Pharmaceuticals' Leases skyrocketed by 5547.11% in 2021 and then tumbled by 1826.95% in 2022.
- Over the past 5 years, Supernus Pharmaceuticals' Leases (Quarter) stood at $35.4 million in 2021, then decreased by 18.27% to $28.9 million in 2022, then grew by 0.31% to $29.0 million in 2023, then dropped by 15.58% to $24.5 million in 2024, then rose by 17.5% to $28.8 million in 2025.
- Its last three reported values are $28.8 million in Q3 2025, $21.9 million for Q2 2025, and $24.5 million during Q4 2024.